"Many of the patients who received vials of compounded semaglutide lacked experience with self-injections, according to the adverse event reports," the FDA said in a July 26 statement
If you experience a suspected side effect from retatrutide within a trial, this should be reported through the trial's pharmacovigilance process
These effects may interfere with post-operative recovery and increase complication risk
How Payer Friction and Patient Drop-Off Undermine Obesity GLP-1 Uptake The GLP-1 market is experiencing unprecedented demand, yet despite its clinical promise for obesity, diabetes, and other conditions, patient behavior and friction throughout the treatment journey continue to erode its commercial potential
GLP1 is a gut-derived polypeptide released from the intestinal L cells, capable of stimulating glucose-dependent insulin secretion and inhibiting food intake by acting on the pancreas and brain, respectively
Named pharmacy: Not publicly disclosed in Omzo's consumer-facing materials as of June 2026